
Sign up to save your podcasts
Or


Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here
By Dr. Neil Love4.9
5656 ratings
Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here

135 Listeners

318 Listeners

493 Listeners

66 Listeners

31 Listeners

76 Listeners

13 Listeners

17 Listeners

12 Listeners

0 Listeners

115 Listeners

57 Listeners

3,334 Listeners

197 Listeners

44 Listeners

22 Listeners

364 Listeners

189 Listeners

43 Listeners

0 Listeners